Cotización Artiva Biotherapeutics - ARTV

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

12.49

Postura de Compra

12.28

Postura de Venta

12.71

Volume Operado de la Acción

14,653

12.49 Rango del Día 12.94

9.68 Rango de 52 semanas 17.31

Capitalización de Mercado [m]

303.374M

Precio Anterior

12.75

Precio de Apertura

12.75

Hora

1200

12.49

Última hora de negociación

11:02:28

Volumen financiero

US$ 184,582

Precio Promedio Ponderado

12.5969

Volumen promedio (3 m)

135,806

Acciones en circulación

24,289,328

Rendimiento del Dividendo

Ratio Precio/Utilidad

-10.42

Beneficio por acción (BPA)

-1.18

turnover

33.49M

Beneficio neto

-28.72M

Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Our product candidates are derived from donor cells (allogeneic) rather than a patients own cells (... Artiva Biotherapeutics is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. Our product candidates are derived from donor cells (allogeneic) rather than a patients own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a patients treatment location, making them what we believe to be off-the-shelf. Our lead product candidate, AlloNK, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs) in an ongoing Phase 1/1b trial in class III or IV lupus nephritis (LN) and a basket investigator-initiated trial (IIT) in multiple autoimmune indications. Mostrar más

Sector

Biological Pds,ex Diagnstics

Industria

Biological Pds,ex Diagnstics

Sitio web

www.artivabio.com

Sede

Dover, Delaware, USA

Fundado

Artiva Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ARTV. The last closing price for Artiva Biotherapeutics was US$12.75. Over the last year, Artiva Biotherapeutics shares have traded in a share price range of US$ 9.68 to US$ 17.31.

Artiva Biotherapeutics currently has 24,289,328 shares in issue. The market capitalisation of Artiva Biotherapeutics is US$309.69 million. Artiva Biotherapeutics has a price to earnings ratio (PE ratio) of -10.42.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.74	6.29787234043	11.75	13.19	11.6148	26411	12.48526552	CS
4	1.04	9.08296943231	11.45	15.49	10	50156	12.15611846	CS
12	0.45	3.73754152824	12.04	17.31	9.68	135806	12.53185717	CS
26	-3.51	-21.9375	16	17.31	9.68	130882	12.16133576	CS
52	-3.51	-21.9375	16	17.31	9.68	130882	12.16133576	CS
156	-3.51	-21.9375	16	17.31	9.68	130882	12.16133576	CS
260	-3.51	-21.9375	16	17.31	9.68	130882	12.16133576	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTNTCheetah Net Supply Chain Service Inc	US$ 5.3324 (185.16%)	101.43M
ZJKZJK Industrial Company Ltd	US$ 16.30 (157.10%)	15.7M
JANXJanux Therapeutics Inc	US$ 62.84 (56.40%)	4.57M
CRDOCredo Technology Group Holding Ltd	US$ 71.38 (49.33%)	10.43M
CTORCitius Oncology Inc	US$ 1.51 (48.04%)	93.73M
REVBRevelation Biosciences Inc	US$ 0.5507 (-42.03%)	2.95M
OMEXOdyssey Marine Exploration Inc	US$ 0.4865 (-34.72%)	3M
STSSSharps Technology Inc	US$ 2.37 (-29.33%)	181.1k
GELSGelteq Ltd	US$ 2.7229 (-28.73%)	220.19k
SNTISenti Biosciences Inc	US$ 7.14 (-28.60%)	5.53M
GWAVGreenwave Technology Solutions Inc	US$ 0.5317 (45.67%)	303.07M
SMCISuper Micro Computer Inc	US$ 40.8356 (-2.77%)	151.79M
CTNTCheetah Net Supply Chain Service Inc	US$ 5.3324 (185.16%)	102.98M
CHRSCoherus BioSciences Inc	US$ 1.9793 (44.47%)	96.84M
CTORCitius Oncology Inc	US$ 1.51 (48.04%)	93.89M